Home    Back

Liposomal t4n5 lotion    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
159Xeroderma pigmentosum1

159. Xeroderma pigmentosum    [ 5 clinical trials,   13 drugs,   (DrugBank: 4 drugs),   4 drug target genes,   13 drug target pathways]
Searched query = "Xeroderma pigmentosum", "XP"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 5 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT00002811
(ClinicalTrials.gov)		July 19961/11/1999T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic Keratoses in Patients With Xeroderma PigmentosumA RANDOMIZED, DOUBLE BLIND, MULTI-CENTER CLINICAL STUDY TO TEST THE SAFETY AND EFFICACY OF T4N5 LIPOSOME LOTION ON PATIENTS WITH XERODERMA PIGMENTOSUM IN THE PROTECTION AGAINST ACTINIC KERATOSESPrecancerous ConditionDrug: liposomal T4N5 lotionApplied GeneticsNULLActive, not recruiting2 Years60 YearsBoth30Phase 3United States;Germany;United Kingdom